ResearcherUniversity of HelsinkiActive in the last 2 years

Santeri Artturi Pakola

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6235-8612; OpenAlex author ID A5009672863. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models. Co-author DOI 10.1007/s00262-025-04072-6 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Akseli Hemminki · 1 shared paper, 2025 · strength 0.20
- Paper Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic c… DOI 10.1007/s00262-025-04072-6 ↗
Hanna E. Seppänen · 1 shared paper, 2025 · strength 0.20
- Paper Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic c… DOI 10.1007/s00262-025-04072-6 ↗
Pauli Antero Puolakkainen · 1 shared paper, 2025 · strength 0.20
- Paper Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic c… DOI 10.1007/s00262-025-04072-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.